Results 31 to 40 of about 422,411 (267)

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

open access: yesMolecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son   +13 more
wiley   +1 more source

Patient experience of negative pressure wound therapy: A qualitative study

open access: yesNursing Open, 2023
Aim This study aimed to clarify the treatment experience of patients undergoing negative pressure wound therapy (NPWT). Design This study used a qualitative design.
Aiko Miyanaga   +5 more
doaj   +1 more source

Design Study of Medical Device [PDF]

open access: yes, 2019
Intense competition has become the norm in most markets in recent years, due to globalization and technology advancements among other reasons [1–3]. Therefore, it is an essential necessity for firms that want to stay relevant and competitive, to seek innovation and creativity in new product development (NPD) process, while trying to maintaining high ...
Burcu Taşkın   +3 more
openaire   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

open access: yesMolecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller   +17 more
wiley   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

open access: yesMolecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone   +11 more
wiley   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Design of a wasp-inspired biopsy needle capable of self-propulsion and friction-based tissue transport

open access: yesFrontiers in Bioengineering and Biotechnology
Percutaneous pancreatic core biopsy is conclusive but challenging due to large-diameter needles, while smaller-diameter needles used in aspiration methods suffer from buckling and clogging.
Jette Bloemberg   +4 more
doaj   +1 more source

Embedded Sensor Systems in Medical Devices: Requisites and Challenges Ahead

open access: yesSensors, 2022
The evolution of technology enables the design of smarter medical devices. Embedded Sensor Systems play an important role, both in monitoring and diagnostic devices for healthcare. The design and development of Embedded Sensor Systems for medical devices
Nerea Arandia   +2 more
doaj   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Medical device design for adolescent adherence and developmental goals: a case study of a cystic fibrosis physiotherapy device

open access: yesPatient Preference and Adherence, 2014
Alexandra R Lang,1 Jennifer L Martin,2 Sarah Sharples,1 John A Crowe3 1Human Factors Research Group, Faculty of Engineering, University of Nottingham, Nottingham, UK; 2Mindtech Healthcare Technology Cooperative (Htc), Faculty of Medicine and Health ...
Lang AR, Martin JL, Sharples S, Crowe JA
doaj  

Home - About - Disclaimer - Privacy